GENENTECH, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1976-01-01
- Employees
- 11.1K
- Market Cap
- -
- Website
- http://www.gene.com
A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed
- Conditions
- Ovarian Cancer
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2017-05-16
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT00097019
A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies
- Conditions
- Psoriasis
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00096980
A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 333
- Registration Number
- NCT00096954
A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT00096941
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Conditions
- Peritoneal CancerFallopian Tube CancerOvarian Cancer
- Interventions
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 131
- Registration Number
- NCT00096993
- Locations
- 🇺🇸
Carle Clinic Association, Urbana, Illinois, United States
🇺🇸Franklin Square Hospital Center, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
- Conditions
- Psoriasis
- First Posted Date
- 2004-11-18
- Last Posted Date
- 2015-07-02
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 1846
- Registration Number
- NCT00096928
- Locations
- 🇺🇸
SunValley Arthritis Center Ltd, Glendale, Arizona, United States
🇺🇸George Washington University Medical Center, Washington, District of Columbia, United States
🇺🇸Dermatology and Advanced Aesthetics, Lake Charles, Louisiana, United States
A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g
- Conditions
- Psoriasis
- First Posted Date
- 2004-11-15
- Last Posted Date
- 2014-03-20
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT00096603
Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD)
- Conditions
- Macular Degeneration
- First Posted Date
- 2004-11-05
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00095433
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
- Conditions
- Non-Small-Cell Lung CarcinomaNeoplasm Recurrence, Local
- First Posted Date
- 2004-11-02
- Last Posted Date
- 2008-01-29
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT00095225
- Locations
- 🇺🇸
Comprehensive Blood and Cancer Center (TORI), Bakersfield, California, United States
🇺🇸Kaiser Permanente Northern CA, Vallejo, California, United States
🇺🇸University of Chicago, Chicago, Illinois, United States
A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- Non-small-cell Lung CarcinomaLung Cancer
- First Posted Date
- 2004-09-16
- Last Posted Date
- 2014-03-04
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 5000
- Registration Number
- NCT00091663
- Locations
- 🇺🇸
Antelope Valley Cancer Center, Lancaster, California, United States
🇺🇸Cancer and Blood Institute Medical Group, Rancho Mirage, California, United States
🇺🇸Utah Hematology and Oncology, Ogden, Utah, United States